地塞米松-话题@MedSci

#地塞米松#

16篇内容 | 4200人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2241409, encodeId=7654224140902, content=<a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=203ce2170be' target=_blank style='color:#2F92EE;'>#皮质类固醇#</a>, objectTitle=【Haematologica】格菲妥单抗前驱用药，皮质类固醇首选地塞米松, objectType=article, longId=854440, objectId=a928854440c4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220906/1662451499353_5552845.jpg, objectUrl=/article/show_article.do?id=a928854440c4, replyNumber=0, likeNumber=0, createdTime=2024-12-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a928854440c4, moduleTitle=【Haematologica】格菲妥单抗前驱用药，皮质类固醇首选地塞米松, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a928854440c4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2239213, encodeId=27c82239213b6, content=<a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=9ac28e2893e' target=_blank style='color:#2F92EE;'>#药代动力学#</a> <a href='/topic/show?id=ebde11012343' target=_blank style='color:#2F92EE;'>#小儿急性淋巴细胞白血病（ALL）#</a>, objectTitle=Eur J Pharm Sci：小儿急性淋巴细胞白血病维持期地塞米松治疗的优化——地塞米松和代谢物的群体药代动力学和药效学研究, objectType=article, longId=852764, objectId=b145852e6473, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241125/1732521143016_8538692.png, objectUrl=/article/show_article.do?id=b145852e6473, replyNumber=0, likeNumber=16, createdTime=2024-11-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b145852e6473, moduleTitle=Eur J Pharm Sci：小儿急性淋巴细胞白血病维持期地塞米松治疗的优化——地塞米松和代谢物的群体药代动力学和药效学研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b145852e6473)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2238690, encodeId=31022238690e8, content=<a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=c34d64e47d1' target=_blank style='color:#2F92EE;'>#泊马度胺#</a> <a href='/topic/show?id=3ec02566625' target=_blank style='color:#2F92EE;'>#伊沙佐米#</a> <a href='/topic/show?id=6ec61050e7b0' target=_blank style='color:#2F92EE;'>#RRMM#</a>, objectTitle=【Haematologica】伊沙佐米、泊马度胺、地塞米松治疗细胞遗传学高危RRMM的2期研究, objectType=article, longId=851640, objectId=7819851640c8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241121/1732153033154_8538692.jpg, objectUrl=/article/show_article.do?id=7819851640c8, replyNumber=0, likeNumber=18, createdTime=2024-11-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=7819851640c8, moduleTitle=【Haematologica】伊沙佐米、泊马度胺、地塞米松治疗细胞遗传学高危RRMM的2期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7819851640c8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2230125, encodeId=63d32230125ae, content=<a href='/topic/show?id=7cd15239687' target=_blank style='color:#2F92EE;'>#急性肾损伤#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=62d2e6828cc' target=_blank style='color:#2F92EE;'>#糖皮质激素#</a>, objectTitle=Sci Transl Med 解密糖皮质激素如何影响 COVID-19 重症患者的肾脏健康, objectType=article, longId=846355, objectId=bc7384635569, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/202401010/1728489957786_9363901.png, objectUrl=/article/show_article.do?id=bc7384635569, replyNumber=0, likeNumber=26, createdTime=2024-10-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2229529, encodeId=988f22295295a, content=<a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=3c9e1105319f' target=_blank style='color:#2F92EE;'>#NDMM#</a>, objectTitle=【Blood】地塞米松剂量强度不影响NDMM生存期, objectType=article, longId=845911, objectId=ec9984591188, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240614/1718360011206_92910.jpg, objectUrl=/article/show_article.do?id=ec9984591188, replyNumber=0, likeNumber=76, createdTime=2024-10-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ec9984591188, moduleTitle=【Blood】地塞米松剂量强度不影响NDMM生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec9984591188)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2227663, encodeId=11dc222e663f5, content=<a href='/topic/show?id=1a632220091' target=_blank style='color:#2F92EE;'>#中性粒细胞减少症#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a>, objectTitle=TRANSFUSION：高剂量粒细胞输注治疗中性粒细胞减少症患者感染的最佳方案:单中心回顾性分析, objectType=article, longId=844791, objectId=1a09844e913e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240725/1721876888294_92910.jpg, objectUrl=/article/show_article.do?id=1a09844e913e, replyNumber=0, likeNumber=61, createdTime=2024-09-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1a09844e913e, moduleTitle=TRANSFUSION：高剂量粒细胞输注治疗中性粒细胞减少症患者感染的最佳方案:单中心回顾性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a09844e913e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2221509, encodeId=7ff1222150945, content=<a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=a5655242963' target=_blank style='color:#2F92EE;'>#急性脑炎#</a> <a href='/topic/show?id=ed70118126ce' target=_blank style='color:#2F92EE;'>#诊断研究#</a>, objectTitle=急性脑炎的治疗, objectType=article, longId=838315, objectId=a416838315da, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240714/1720949737178_5579292.jpg, objectUrl=/article/show_article.do?id=a416838315da, replyNumber=0, likeNumber=94, createdTime=2024-08-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a416838315da, moduleTitle=急性脑炎的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a416838315da)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2218364, encodeId=537d221836475, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=518761566e4' target=_blank style='color:#2F92EE;'>#来那度胺#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=c34d64e47d1' target=_blank style='color:#2F92EE;'>#泊马度胺#</a> <a href='/topic/show?id=3ec02566625' target=_blank style='color:#2F92EE;'>#伊沙佐米#</a>, objectTitle=【Blood Adv】伊沙佐米、泊马度胺、地塞米松治疗首次复发的来那度胺难治性骨髓瘤的II期研究, objectType=article, longId=837444, objectId=a9fb83e4442b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240802/1722575535210_8538692.jpg, objectUrl=/article/show_article.do?id=a9fb83e4442b, replyNumber=0, likeNumber=89, createdTime=2024-08-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a9fb83e4442b, moduleTitle=【Blood Adv】伊沙佐米、泊马度胺、地塞米松治疗首次复发的来那度胺难治性骨髓瘤的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9fb83e4442b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2213846, encodeId=49e52213846cf, content=<a href='/topic/show?id=f52851329b' target=_blank style='color:#2F92EE;'>#Covid-19#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=2b85362063c' target=_blank style='color:#2F92EE;'>#单核细胞#</a>, objectTitle=Cell：新研究揭示地塞米松对一些重度新冠患者的救命作用与单核细胞反应有关, objectType=article, longId=833581, objectId=a43b83358112, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240707/1720353282015_2185383.png, objectUrl=/article/show_article.do?id=a43b83358112, replyNumber=0, likeNumber=171, createdTime=2024-07-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2213418, encodeId=f6762213418e4, content=<a href='/topic/show?id=73216852458' target=_blank style='color:#2F92EE;'>#环磷酰胺#</a> <a href='/topic/show?id=0360144540e' target=_blank style='color:#2F92EE;'>#POEMS综合征#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=3ec02566625' target=_blank style='color:#2F92EE;'>#伊沙佐米#</a>, objectTitle=【BJH】伊沙佐米、环磷酰胺、地塞米松治疗新诊断POEMS综合征的疗效和安全性, objectType=article, longId=833004, objectId=fe75833004d3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240705/1720150785862_5579292.jpg, objectUrl=/article/show_article.do?id=fe75833004d3, replyNumber=0, likeNumber=86, createdTime=2024-07-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fe75833004d3, moduleTitle=【BJH】伊沙佐米、环磷酰胺、地塞米松治疗新诊断POEMS综合征的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe75833004d3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2212995, encodeId=33d422129950c, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=3ec02566625' target=_blank style='color:#2F92EE;'>#伊沙佐米#</a> <a href='/topic/show?id=7f389396e27' target=_blank style='color:#2F92EE;'>#达雷妥尤单抗#</a>, objectTitle=【AJH】伊沙佐米、达雷妥尤单抗、地塞米松治疗RRMM的2期研究结果, objectType=article, longId=832650, objectId=56c18326500f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240703/1719977403583_5579292.png, objectUrl=/article/show_article.do?id=56c18326500f, replyNumber=0, likeNumber=147, createdTime=2024-07-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=56c18326500f, moduleTitle=【AJH】伊沙佐米、达雷妥尤单抗、地塞米松治疗RRMM的2期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56c18326500f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2209282, encodeId=08472209282e1, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=518761566e4' target=_blank style='color:#2F92EE;'>#来那度胺#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=901a1153803e' target=_blank style='color:#2F92EE;'>#Dara-KRd#</a>, objectTitle=【BCJ】24周期Dara-KRd不伴移植治疗新诊断多发性骨髓瘤的II期研究结果, objectType=article, longId=829410, objectId=ee6282941093, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240610/1718033892155_5579292.png, objectUrl=/article/show_article.do?id=ee6282941093, replyNumber=0, likeNumber=130, createdTime=2024-06-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ee6282941093, moduleTitle=【BCJ】24周期Dara-KRd不伴移植治疗新诊断多发性骨髓瘤的II期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee6282941093)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2207616, encodeId=af07220e6163b, content=<a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=3146892e7c7' target=_blank style='color:#2F92EE;'>#血液恶性肿瘤#</a> <a href='/topic/show?id=f52851329b' target=_blank style='color:#2F92EE;'>#Covid-19#</a>, objectTitle=Haematologica：地塞米松治疗COVID-19增加血液恶性肿瘤患者死亡率, objectType=article, longId=828174, objectId=6f7a8281e4c0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240530/1717040917076_5579292.jpg, objectUrl=/article/show_article.do?id=6f7a8281e4c0, replyNumber=0, likeNumber=191, createdTime=2024-05-31, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6f7a8281e4c0, moduleTitle=Haematologica：地塞米松治疗COVID-19增加血液恶性肿瘤患者死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f7a8281e4c0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2203437, encodeId=46f6220343e1f, content=<a href='/topic/show?id=5ccae366556' target=_blank style='color:#2F92EE;'>#硼替佐米#</a> <a href='/topic/show?id=c4a844521e5' target=_blank style='color:#2F92EE;'>#套细胞淋巴瘤#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a>, objectTitle=Leukemia：硼替佐米+ R-HAD治疗R/R MCL的3期研究结果, objectType=article, longId=824888, objectId=c5f8824888c2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=c5f8824888c2, replyNumber=0, likeNumber=155, createdTime=2024-05-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c5f8824888c2, moduleTitle=Leukemia：硼替佐米+ R-HAD治疗R/R MCL的3期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5f8824888c2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195820, encodeId=646d219582061, content=<a href='/topic/show?id=0b8611283e05' target=_blank style='color:#2F92EE;'>#激素退烧#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=3b746980125' target=_blank style='color:#2F92EE;'>#甲强龙#</a>, objectTitle=激素退烧到底是用「地塞米松」还是「甲强龙」？, objectType=article, longId=818152, objectId=c6e881815285, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016434455_4754896.png, objectUrl=/article/show_article.do?id=c6e881815285, replyNumber=0, likeNumber=115, createdTime=2024-03-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c6e881815285, moduleTitle=激素退烧到底是用「地塞米松」还是「甲强龙」？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6e881815285)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2194028, encodeId=e45a21940280c, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=ff1c3654ebf' target=_blank style='color:#2F92EE;'>#卡非佐米#</a> <a href='/topic/show?id=21d764465c7' target=_blank style='color:#2F92EE;'>#沙利度胺#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a>, objectTitle=Haematologica | 卡非佐米、沙利度胺和地塞米松用于多发性骨髓瘤复发或难治患者：ALLG MM018/AMN002 单臂多中心II期研究的最终报告, objectType=article, longId=817445, objectId=402581e445ba, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240318/1710773828708_6145188.png, objectUrl=/article/show_article.do?id=402581e445ba, replyNumber=0, likeNumber=120, createdTime=2024-03-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=402581e445ba, moduleTitle=Haematologica | 卡非佐米、沙利度胺和地塞米松用于多发性骨髓瘤复发或难治患者：ALLG MM018/AMN002 单臂多中心II期研究的最终报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=402581e445ba)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2192245, encodeId=b9722192245de, content=<a href='/topic/show?id=8e0d10065ff' target=_blank style='color:#2F92EE;'>#isatuximab#</a> <a href='/topic/show?id=c34d64e47d1' target=_blank style='color:#2F92EE;'>#泊马度胺#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=79f9112091aa' target=_blank style='color:#2F92EE;'>#难治性多发性骨髓瘤#</a>, objectTitle=【血液学】Isatuximab+泊马度胺+地塞米松治疗RRMM的3期研究最终OS结果, objectType=article, longId=816538, objectId=d333816538ff, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=d333816538ff, replyNumber=0, likeNumber=108, createdTime=2024-03-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d333816538ff, moduleTitle=【血液学】Isatuximab+泊马度胺+地塞米松治疗RRMM的3期研究最终OS结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d333816538ff)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2191184, encodeId=c5ef21911846d, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=5ccae366556' target=_blank style='color:#2F92EE;'>#硼替佐米#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=9eb09396903' target=_blank style='color:#2F92EE;'>#达雷木单抗#</a> <a href='/topic/show?id=b8dc111936b6' target=_blank style='color:#2F92EE;'>#塞利尼索(selinexor)#</a>, objectTitle=Haematologica | 塞利尼索 + 达雷木单抗 + 硼替佐米 + 地塞米松四联疗法治疗复发难治性多发性骨髓瘤的II期临床研究, objectType=article, longId=816015, objectId=03c381601523, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/ksumc-evidencebased-clinical-practice-guidelines-program-overview-20132014-1-638.jpg, objectUrl=/article/show_article.do?id=03c381601523, replyNumber=0, likeNumber=119, createdTime=2024-03-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=03c381601523, moduleTitle=Haematologica | 塞利尼索 + 达雷木单抗 + 硼替佐米 + 地塞米松四联疗法治疗复发难治性多发性骨髓瘤的II期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03c381601523)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190377, encodeId=68f521903e7ff, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=3ec02566625' target=_blank style='color:#2F92EE;'>#伊沙佐米#</a> <a href='/topic/show?id=7f389396e27' target=_blank style='color:#2F92EE;'>#达雷妥尤单抗#</a> <a href='/topic/show?id=12ab111e84e7' target=_blank style='color:#2F92EE;'>#来那度胺暴露#</a>, objectTitle=【AJH】达雷妥尤单抗+伊沙佐米+地塞米松治疗来那度胺暴露二线RRMM的2期DARIA研究结果, objectType=article, longId=815280, objectId=9d6981528062, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/busy-hospital-corridor-with-medical-staff-and-PHNLKBC.jpg, objectUrl=/article/show_article.do?id=9d6981528062, replyNumber=0, likeNumber=89, createdTime=2024-03-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9d6981528062, moduleTitle=【AJH】达雷妥尤单抗+伊沙佐米+地塞米松治疗来那度胺暴露二线RRMM的2期DARIA研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d6981528062)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188739, encodeId=fb612188e39c8, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=a4671201218' target=_blank style='color:#2F92EE;'>#MM#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=7f389396e27' target=_blank style='color:#2F92EE;'>#达雷妥尤单抗#</a> <a href='/topic/show?id=1bf011141e3e' target=_blank style='color:#2F92EE;'>#塞利尼索#</a>, objectTitle=【Haematologica】塞利尼索+达雷妥尤单抗+Vd治疗RRMM的II期研究, objectType=article, longId=814080, objectId=882f81408000, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-writing-D3K6QME.jpg, objectUrl=/article/show_article.do?id=882f81408000, replyNumber=0, likeNumber=100, createdTime=2024-02-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=882f81408000, moduleTitle=【Haematologica】塞利尼索+达雷妥尤单抗+Vd治疗RRMM的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=882f81408000)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯话题小助手

地塞米松

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#地塞米松# #皮质类固醇#

【Haematologica】格菲妥单抗前驱用药，皮质类固醇首选地塞米松

2024-12-08发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#地塞米松# #药代动力学# #小儿急性淋巴细胞白血病（ALL）#

Eur J Pharm Sci：小儿急性淋巴细胞白血病维持期地塞米松治疗的优化——地塞米松和代谢物的群体药代动力学和药效学研究

2024-11-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#地塞米松# #泊马度胺# #伊沙佐米# #RRMM#

【Haematologica】伊沙佐米、泊马度胺、地塞米松治疗细胞遗传学高危RRMM的2期研究

2024-11-23发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#急性肾损伤# #地塞米松# #糖皮质激素#

2024-10-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#地塞米松# #NDMM#

【Blood】地塞米松剂量强度不影响NDMM生存期

2024-10-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#中性粒细胞减少症# #地塞米松#

TRANSFUSION：高剂量粒细胞输注治疗中性粒细胞减少症患者感染的最佳方案:单中心回顾性分析

2024-09-25发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#地塞米松# #急性脑炎# #诊断研究#

急性脑炎的治疗

2024-08-20发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #来那度胺# #地塞米松# #泊马度胺# #伊沙佐米#

【Blood Adv】伊沙佐米、泊马度胺、地塞米松治疗首次复发的来那度胺难治性骨髓瘤的II期研究

2024-08-03发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#Covid-19# #地塞米松# #单核细胞#

2024-07-08发表于上海

梅斯管理员 (审核中...)